Comments regarding use of rifabutin for eradication.
作者信息
Graham David Y
机构信息
Department of Medicine, Michael E. DeBakey Veterans Affairs Medical Center and Baylor College of Medicine, RM 3C-190 (111D), 2002 Holcombe Boulevard, Houston, TX 77030, USA.
出版信息
Therap Adv Gastroenterol. 2021 Oct 8;14:17562848211044064. doi: 10.1177/17562848211044064. eCollection 2021.
Abstract
摘要
相似文献
1
Comments regarding use of rifabutin for eradication.关于使用利福布汀进行根除治疗的评论。
Therap Adv Gastroenterol. 2021 Oct 8;14:17562848211044064. doi: 10.1177/17562848211044064. eCollection 2021.
2
Rifabutin-based Fourth and Fifth-line Rescue Therapy in Patients with for Eradication Failure.基于利福布汀的第四线和第五线挽救疗法用于根除治疗失败的患者。
Korean J Gastroenterol. 2017 Feb 25;69(2):109-118. doi: 10.4166/kjg.2017.69.2.109.
3
[Comparison of rifabutin- and levofloxacin-based third-line rescue therapies for Helicobacter pylori].基于利福布汀和左氧氟沙星的幽门螺杆菌三线挽救治疗的比较
Korean J Gastroenterol. 2012 Jun 25;59(6):401-6. doi: 10.4166/kjg.2012.59.6.401.
4
Evaluating treatments with rifabutin and amoxicillin for eradication of Helicobacter pylori infection in adults: a systematic review.评估利福布汀和阿莫西林联合治疗成人幽门螺杆菌感染的疗效：系统评价。
Expert Opin Pharmacother. 2022 Feb;23(2):201-210. doi: 10.1080/14656566.2021.1982894. Epub 2021 Oct 7.
5
Rifabutin- and furazolidone-based Helicobacter pylori eradication therapies after failure of standard first- and second-line eradication attempts in dyspepsia patients.在消化不良患者标准一线和二线根除治疗失败后，基于利福布汀和呋喃唑酮的幽门螺杆菌根除疗法
Aliment Pharmacol Ther. 2005 Jan 1;21(1):91-6. doi: 10.1111/j.1365-2036.2004.02210.x.
6
Rifabutin for the Treatment of Infection: A Review.利福布汀用于感染治疗的综述
Pathogens. 2020 Dec 28;10(1):15. doi: 10.3390/pathogens10010015.
7
Rifabutin-Based Triple Therapy (RHB-105) for Eradication: A Double-Blind, Randomized, Controlled Trial.利福布丁三联疗法（RHB-105）根除幽门螺杆菌：一项双盲、随机、对照试验。
Ann Intern Med. 2020 Jun 16;172(12):795-802. doi: 10.7326/M19-3734. Epub 2020 May 5.
8
Efficacy and safety of a new rifabutin-based triple therapy with vonoprazan for refractory Helicobacter pylori infection: A prospective single-arm study.新型含利福布汀三联疗法联合沃诺拉赞治疗难治性幽门螺杆菌感染的疗效和安全性：一项前瞻性单臂研究。
Helicobacter. 2020 Oct;25(5):e12719. doi: 10.1111/hel.12719. Epub 2020 Jun 29.
9
Efficacy and safety of low-dose rifabutin-based 7-day triple therapy as a third- or later-line Helicobacter pylori eradication regimen.低剂量利福布汀为基础的 7 天三联疗法作为三线或更后线幽门螺杆菌根除方案的疗效和安全性。
Helicobacter. 2022 Aug;27(4):e12900. doi: 10.1111/hel.12900. Epub 2022 May 29.
10
Rifabutin as salvage therapy for eradication: Cornerstones and novelties.利福布汀作为补救治疗根除的选择：要点和新进展。
World J Gastroenterol. 2022 Dec 7;28(45):6356-6362. doi: 10.3748/wjg.v28.i45.6356.
本文引用的文献
1
The status and progress of first-line treatment against infection: a review.抗感染一线治疗的现状与进展：综述
Therap Adv Gastroenterol. 2021 Jun 28;14:1756284821989177. doi: 10.1177/1756284821989177. eCollection 2021.
2
Rifabutin for the Treatment of Infection: A Review.利福布汀用于感染治疗的综述
Pathogens. 2020 Dec 28;10(1):15. doi: 10.3390/pathogens10010015.
3
Rifabutin-Containing Triple Therapy (RHB-105) for Eradication of : Randomized ERADICATE Hp Trial.含利福布汀的三联疗法（RHB-105）用于根除幽门螺杆菌：随机化ERADICATE Hp试验
Antibiotics (Basel). 2020 Oct 9;9(10):685. doi: 10.3390/antibiotics9100685.
4
Rifabutin-Based Triple Therapy (RHB-105) for Eradication: A Double-Blind, Randomized, Controlled Trial.利福布丁三联疗法（RHB-105）根除幽门螺杆菌：一项双盲、随机、对照试验。
Ann Intern Med. 2020 Jun 16;172(12):795-802. doi: 10.7326/M19-3734. Epub 2020 May 5.
5
Rifabutin: where do we stand in 2016?利福布汀：2016 年我们的处境如何？
J Antimicrob Chemother. 2016 Jul;71(7):1759-71. doi: 10.1093/jac/dkw024. Epub 2016 Mar 23.
6
Review article: rifabutin in the treatment of refractory Helicobacter pylori infection.综述文章：利福布汀治疗难治性幽门螺杆菌感染。
Aliment Pharmacol Ther. 2012 Jan;35(2):209-21. doi: 10.1111/j.1365-2036.2011.04937.x. Epub 2011 Nov 30.
7
Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.1997年至2000年在纽约市接受基于利福平或利福布汀治疗方案的HIV感染结核病患者的复发及获得性利福平耐药情况。
Clin Infect Dis. 2005 Jul 1;41(1):83-91. doi: 10.1086/430377. Epub 2005 May 26.
8
Rifampin and rifabutin resistance mechanism in Helicobacter pylori.幽门螺杆菌对利福平及利福布汀的耐药机制
Antimicrob Agents Chemother. 1999 Jun;43(6):1497-9. doi: 10.1128/AAC.43.6.1497.
Zotero 插件